Literature DB >> 16537824

What's the rush? The dissemination and adoption of preliminary research results.

Steven Woloshin, Lisa M Schwartz.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16537824     DOI： 10.1093/jnci/djj115

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Media Reporting of Practice-Changing Clinical Trials in Oncology: A North American Perspective.

Authors:  Peter Andrew; Michael M Vickers; Stephen O'Connor; Mario Valdes; Patricia A Tang
Journal:  Oncologist       Date:  2016-02-26

2.  Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.

Authors:  Jeremy M O'Connor; Kristen L Fessele; Jean Steiner; Kathi Seidl-Rathkopf; Kenneth R Carson; Nathan C Nussbaum; Emily S Yin; Kerin B Adelson; Carolyn J Presley; Anne C Chiang; Joseph S Ross; Amy P Abernethy; Cary P Gross
Journal:  JAMA Oncol       Date:  2018-08-09       Impact factor: 31.777

3.  Characteristics of medical research news reported on front pages of newspapers.

Authors:  William Yuk Yeu Lai; Trevor Lane
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

4.  Media Hyping and the "Herceptin Access Story": An Analysis of Canadian and UK Newspaper Coverage.

Authors:  Julia Abelson; Patricia A Collins
Journal:  Healthc Policy       Date:  2009-02

Review 5.  Treatment of premenopausal women with early breast cancer: old challenges and new opportunities.

Authors:  Stefan Aebi; Olivia Pagani
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma.

Authors:  Roger Y Kim; Nandita Mitra; Stephen J Bagley; Melina E Marmarelis; Andrew R Haas; Katharine A Rendle; Anil Vachani
Journal:  JTO Clin Res Rep       Date:  2021-05-18

7.  Quality of pharmaceutical industry press releases based on original research.

Authors:  Bindee Kuriya; Elana C Schneid; Chaim M Bell
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

8.  Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?

Authors:  L J Esserman; M D Alvarado; R J Howe; A J Mohan; B Harrison; C Park; C O'Donoghue; E M Ozanne
Journal:  Breast Cancer Res Treat       Date:  2014-03-02       Impact factor: 4.872
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.